Pagoclone Indevus.
Article Details
- CitationCopy to clipboard
Bateson A
Pagoclone Indevus.
Curr Opin Investig Drugs. 2003 Jan;4(1):91-5.
- PubMed ID
- 12625036 [ View in PubMed]
- Abstract
Pagoclone is a cyclopyrrolone GABAA receptor modulator under development by Indevus for the potential treatment of panic and anxiety disorders. Indevus initiated phase II/III trials in November 1996. Pfizer had initiated a phase III trial for panic disorder in August 2000 but discontinued development of the compound in June 2002.
DrugBank Data that Cites this Article
- Drugs